It has been known for many years that FGF8 and FGF10, both ligands for FGFR2, are overexpressed in human breast tumors [37,38], suggesting that antibodies to screen for active FGFR2 would be very useful. The gene discussed is FGFR2; the disease is breast neoplasm.